How to Buy Advanced Enzyme Technologies Ltd Shares?
You can easily buy the stocks/shares of Advanced Enzyme Technologies Ltd (ADVENZYMES) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Advanced Enzyme Technologies Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ADVENZYMES as on 15th May 2025 is ₹286.27What is the return on Advanced Enzyme Technologies Ltd share?
The past returns of Advanced Enzyme Technologies Ltd (ADVENZYMES) share are- Past 1 week: N/A
- Past 1 month: -93.01
- Past 3 months: 20.07
- Past 6 months: -15.05
- Past 1 year: -16.03
- Past 3 years: 10.17
- Past 5 years: 94.60
What is the Dividend yield % on Advanced Enzyme Technologies Ltd share?
The current dividend yield of Advanced Enzyme Technologies Ltd (ADVENZYMES) is 1.62What is the Market Cap of Advanced Enzyme Technologies Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹3582.17Cr as of 15th May 2025What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd?
The 52-week high and low of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹571 and ₹257.90.What is the PE and PB ratio of Advanced Enzyme Technologies Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Advanced Enzyme Technologies Ltd are 27.32 and 2.61 respectively.Which sector does Advanced Enzyme Technologies Ltd belong to?
Advanced Enzyme Technologies Ltd (ADVENZYMES) belongs to the Materials sector & Specialty Chemicals sub-sector.What are the peers or stocks similar to Advanced Enzyme Technologies Ltd?
The peers or stocks similar to Advanced Enzyme Technologies Ltd are: and many others.Can't decide whether or not to buy Advanced Enzyme Technologies Ltd?
Worry no more! Login to Tickertape and check out Advanced Enzyme Technologies Ltd (ADVENZYMES) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Advanced Enzyme Technologies Ltd?
The 52-week high and low of Advanced Enzyme Technologies Ltd (ADVENZYMES) is ₹571 and ₹257.90.1. Test Stocks FAQ for Advanced Enzyme Technologies Ltd Shares?
You can easily buy the stocks/shares of Advanced Enzyme Technologies Ltd (ADVENZYMES) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Advanced Enzyme Technologies Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of ADVENZYMES as on 15th May 2025 is ₹286.27
Advanced Enzyme Technologies Ltd
ADVENZYMES Share Price
286.270.06% (-0.18)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
ADVENZYMES Performance & Key Metrics
ADVENZYMES Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 27.32 | 2.61 | 1.62% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 27.21 | 3.46 | 1.60% |
ADVENZYMES Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
ADVENZYMES Company Profile
Advanced Enzyme Technologies is engaged in the research and development, manufacturing and marketing of over 400 products developed from over 60 indigenous enzymes.
FLUOROCHEM
PE Ratio
74.89
74.89
1Y Return
13.26%
13.26%
Buy Reco %
100.00
100.00
NAVINFLUOR
PE Ratio
77.98
77.98
1Y Return
27.56%
27.56%
Buy Reco %
57.14
57.14
VINATIORGA
PE Ratio
48.05
48.05
1Y Return
0.58%
0.58%
Buy Reco %
75.00
75.00
AARTIIND
PE Ratio
50.54
50.54
1Y Return
31.57%
31.57%
Buy Reco %
57.14
57.14
PE Ratio
58.99
58.99
1Y Return
7.21%
7.21%
Buy Reco %
42.86
42.86
ADVENZYMES Sentiment Analysis
ADVENZYMES Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
ADVENZYMES Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
ADVENZYMES Stock Growth Drivers
ADVENZYMES Stock Growth Drivers
0
Hmm, looks like there are nogrowth drivers
ADVENZYMES Stock Challenges
ADVENZYMES Stock Challenges
5Deposit Growth Shortfalls
The company has experienced deposit growth that has not met expectations, attributed to seasonal trends
Loan Growth Concerns
There is uncertainty regarding the company's loan deposit ratio (LDR) and its implications for loan
ADVENZYMES Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
ADVENZYMES Forecasts
Price
Revenue
Earnings
ADVENZYMES Share Price Forecast
ADVENZYMES Share Price Forecast
2025
Current
₹320.60
Baseline
Forecast for Jan 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹320.60
Baseline
Forecast for Jan 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
ADVENZYMES Company Revenue Forecast
ADVENZYMES Company Revenue Forecast
2025
Current
₹669.95
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹669.95
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
ADVENZYMES Stock EPS (Earnings Per Share) Forecast
ADVENZYMES Stock EPS (Earnings Per Share) Forecast
2025
Current
₹11.72
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹11.72
Baseline
Forecast for Mar 2025
High
₹—
Median
₹—
Low
₹—
All values in ₹
ADVENZYMES
ADVENZYMES
Income
Balance Sheet
Cash Flow
Annual Normal View
ADVENZYMES Income Statement
ADVENZYMES Income Statement
Annual Normal View
| Financial Year | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 331.57 | 392.41 | 424.63 | 449.63 | 510.69 | 535.80 | 566.10 | 660.53 | 669.95 | 669.95 | ||||||||||
Raw Materials | 70.14 | 80.33 | 65.95 | 90.83 | 100.21 | 130.32 | 127.53 | 155.47 | 442.47 | 442.48 | ||||||||||
| Power & Fuel Cost | 12.87 | 18.10 | 19.29 | 19.37 | 21.45 | 29.95 | 38.10 | 40.92 | ||||||||||||
| Employee Cost | 50.70 | 68.60 | 80.23 | 80.19 | 87.11 | 103.96 | 114.80 | 128.37 | ||||||||||||
| Selling & Administrative Expenses | 25.61 | 38.41 | 40.04 | 37.58 | 37.72 | 51.80 | 56.22 | 60.11 | ||||||||||||
| Operating & Other expenses | 18.00 | 20.64 | 30.84 | 12.65 | 22.78 | 10.77 | 50.56 | 48.48 | ||||||||||||
EBITDA | 154.25 | 166.33 | 188.28 | 209.01 | 241.42 | 209.00 | 178.89 | 227.18 | 227.48 | 227.47 | ||||||||||
| Depreciation/Amortization | 12.76 | 18.30 | 21.12 | 25.78 | 28.72 | 34.98 | 35.03 | 35.24 | 36.56 | 36.56 | ||||||||||
| PBIT | 141.49 | 148.03 | 167.16 | 183.23 | 212.70 | 174.02 | 143.86 | 191.94 | 190.92 | 190.91 | ||||||||||
| Interest & Other Items | 4.43 | 9.06 | 5.20 | 4.08 | 2.57 | 2.96 | 3.48 | 4.12 | 3.56 | 3.55 | ||||||||||
| PBT | 137.06 | 138.97 | 161.96 | 179.15 | 210.13 | 171.06 | 140.38 | 187.82 | 187.36 | 187.36 | ||||||||||
| Taxes & Other Items | 45.51 | 48.91 | 50.90 | 49.87 | 64.21 | 51.48 | 34.75 | 54.52 | 56.25 | 56.24 | ||||||||||
| Net Income | 91.55 | 90.06 | 111.06 | 129.28 | 145.92 | 119.58 | 105.63 | 133.30 | 131.11 | 131.12 | ||||||||||
| EPS | 2.79 | 8.07 | 9.95 | 11.58 | 13.06 | 10.70 | 9.45 | 11.92 | 11.72 | 11.73 | ||||||||||
| DPS | 0.08 | 0.50 | 0.60 | 0.60 | 0.90 | 1.00 | 1.00 | 5.10 | 5.20 | 2.20 | ||||||||||
| Payout ratio | 0.03 | 0.06 | 0.06 | 0.05 | 0.07 | 0.09 | 0.11 | 0.43 | 0.44 | 0.19 |
ADVENZYMES Company Updates
FY 2025FY 2025
Investor Presentation
May 13PDF
Feb 8PDF
Nov 9PDF
ADVENZYMES Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
ADVENZYMES Past Performance & Peer Comparison
ADVENZYMES Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation-basic on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Advanced Enzyme Technologies Ltd | 27.32 | 2.61 | 1.62% |
| Gujarat Fluorochemicals Ltd | 74.89 | 6.89 | — |
| Navin Fluorine International Ltd | 77.98 | 9.44 | 0.26% |
| Vinati Organics Ltd | 48.05 | 7.91 | 0.40% |
ADVENZYMES Stock Price Comparison
Compare ADVENZYMES with any stock or ETFCompare ADVENZYMES with any stock or ETF
ADVENZYMES
ADVENZYMES Holdings
ADVENZYMES Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
ADVENZYMES Promoter Holdings Trend
ADVENZYMES Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
ADVENZYMES Institutional Holdings Trend
ADVENZYMES Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
ADVENZYMES Shareholding Pattern
ADVENZYMES Shareholding Pattern
ADVENZYMES Shareholding History
ADVENZYMES Shareholding History
Foreign Institutions
Mutual Funds Invested in ADVENZYMES
Mutual Funds Invested in ADVENZYMES
No mutual funds holding trends are available
Top 5 Mutual Funds holding Advanced Enzyme Technologies Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.0440% | Percentage of the fund’s portfolio invested in the stock 0.32% | Change in the portfolio weight of the stock over the last 3 months 0.32% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 74/87 (-39) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.1017% | Percentage of the fund’s portfolio invested in the stock 1.42% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 22/47 (-1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.8253% | Percentage of the fund’s portfolio invested in the stock 1.06% | Change in the portfolio weight of the stock over the last 3 months 1.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 35/52 (+7) |
Compare 3-month MF holding change on Screener
smallcases containing ADVENZYMES stock
smallcases containing ADVENZYMES stock
Looks like this stock is not in any smallcase yet.
ADVENZYMES Events
ADVENZYMES Events
ADVENZYMES Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ADVENZYMES has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.62%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹16.23 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
ADVENZYMES Dividend Trend
No Dividend Cuts
Dividends are the portion of earnings that a company distributes to all its shareholders every year
ADVENZYMES has increased or maintained dividend levels over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 1.62%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹16.23 every year
ADVENZYMES Upcoming Dividends
ADVENZYMES Upcoming Dividends
Cash Dividend
Ex DateEx DateJul 23, 2025
Final
Final | Div/Share: ₹1.20
Dividend/Share
₹1.20
Ex DateEx Date
Jul 23, 2025
ADVENZYMES Past Dividends
ADVENZYMES Past Dividends
Cash Dividend
Ex DateEx DateMay 16, 2025
Interim
Interim | Div/Share: ₹4.00
Dividend/Share
₹4.00
Ex DateEx Date
May 16, 2025
Cash Dividend
Ex DateEx DateJul 18, 2024
Final
Final | Div/Share: ₹1.10
Dividend/Share
₹1.10
Ex DateEx Date
Jul 18, 2024
Cash Dividend
Ex DateEx DateJul 17, 2024
Final
Final | Div/Share: ₹1.10
Dividend/Share
₹1.10
Ex DateEx Date
Jul 17, 2024
Cash Dividend
Ex DateEx DateAug 11, 2022
Final
Final | Div/Share: ₹1.00
Dividend/Share
₹1.00
Ex DateEx Date
Aug 11, 2022
Cash Dividend
Ex DateEx DateAug 31, 2021
Final
Final | Div/Share: ₹0.90
Dividend/Share
₹0.90
Ex DateEx Date
Aug 31, 2021
ADVENZYMES Stock News & Opinions
ADVENZYMES Stock News & Opinions
Articles & Videos
Corporate
Advanced Enzyme Techs. to declare Quarterly Results
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to declare Quarterly Results
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 13 May 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Advanced Enzyme Technologies allots 500 equity shares under ESOS
Advanced Enzyme Technologies has allotted 500 equity shares under ESOS on 19 March 2025. Consequent to the said allotment, the paid-up share capital of the Company stands increased from Rs 22,37,61,300 comprising of 11,18,80,650 equity shares of Rs 2 each to Rs 22,37,62,300 comprising of 11,18,81,150 equity shares of Rs 2 each. Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit declines 9.86% in the December 2024 quarter
Net profit of Advanced Enzyme Technologies declined 9.86% to Rs 37.65 crore in the quarter ended December 2024 as against Rs 41.77 crore during the previous quarter ended December 2023. Sales rose 5.08% to Rs 169.11 crore in the quarter ended December 2024 as against Rs 160.94 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales169.11160.94 5 OPM %32.6733.40 - PBDT61.9967.48 -8 PBT53.0258.88 -10 NP37.6541.77 -10 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to announce Quarterly Result
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 8 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Advanced Enzyme Tech drops after PAT slides 5% YoY in Q2 FY25
The revenue de-grew by 3% in Americas, 27% in Europe, 9% in Asia (ex-India) while it grew by 8% in rest of the world. On the segmental front, the revenue from human nutrition segment declined by 2% YoY to Rs 99.2 crore while animal nutrition income grew by 6% YoY to Rs 18.1 crore in second quarter of FY25. The bio-processing segment revenue slipped 33% to Rs 16.8 crore while specialized manufacturing segment rose 9% to Rs 12 crore in September 2024 quarter over September 2023 quarter. The domestic sales constituted about 48% of revenue from operations during Q2 FY25 as compared to 52% during Q2 FY24. International sales were 52% of revenue from operations during Q2 FY25 as compared to 48% during same quarter last year. EBITDA de-grew by 17% YoY to Rs 42.4 crore in the second quarter. EBITDA margin was 29% and PAT margin stood at 23% during the quarter. Profit before tax was at Rs 42.21 crore during Q2 of FY25, down 11.93% YoY. On outlook front, the company stated, 'Advanced Enzymes is constantly working towards improving and strengthening its business model, and will continue to focus on all three divisions - Human Nutrition, Animal Nutrition and Bio-Processing including developing, adding and launching more products in the target market of probiotics. The company is confident that its existing capacities and capital investments would serve well to expand its enzymes and probiotics business.' Advanced Enzyme Technologies is a research driven company with global leadership in the manufacturing of enzymes and probiotics. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. Its aim is to replace traditionally used chemicals with eco-friendly enzymatic solutions. Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit declines 4.59% in the September 2024 quarter
Net profit of Advanced Enzyme Technologies declined 4.59% to Rs 32.83 crore in the quarter ended September 2024 as against Rs 34.41 crore during the previous quarter ended September 2023. Sales declined 7.44% to Rs 146.10 crore in the quarter ended September 2024 as against Rs 157.84 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales146.10157.84 -7 OPM %29.0332.51 - PBDT51.1056.65 -10 PBT42.2147.93 -12 NP32.8334.41 -5 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. to table results
Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 9 November 2024Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Advanced Enzyme Technologies consolidated net profit rises 18.54% in the June 2024 quarter
Net profit of Advanced Enzyme Technologies rose 18.54% to Rs 34.15 crore in the quarter ended June 2024 as against Rs 28.81 crore during the previous quarter ended June 2023. Sales rose 4.92% to Rs 154.52 crore in the quarter ended June 2024 as against Rs 147.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales154.52147.28 5 OPM %33.1229.89 - PBDT57.2950.04 14 PBT48.6741.41 18 NP34.1528.81 19 Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Advanced Enzyme Techs. schedules AGM
Advanced Enzyme Techs. announced that the 35th Annual General Meeting (AGM) of the company will be held on 25 July 2024.Powered by Capital Market - Live News
11 months agoCapital Markets
Over the last 5 years, revenue has grown at a yearly rate of 9.24%, vs industry avg of 6.08%
Over the last 5 years, market share decreased from 0.76% to 0.75%
Over the last 5 years, net income has grown at a yearly rate of 3.72%, vs industry avg of -1.03%